MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+17.61%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$556M
AUM Growth
+$556M
(+5.3%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-6.46%
Top 10 Holdings %
Top 10 Hldgs %
17.22%
Holding
230
New
38
Increased
44
Reduced
92
Closed
35
Top Buys
| 1 |
The Bancorp
TBBK
|
$7.18M |
| 2 |
Light & Wonder
LNW
|
$6.85M |
| 3 |
e.l.f. Beauty
ELF
|
$5.07M |
| 4 |
ESCO Technologies
ESE
|
$4.49M |
| 5 |
Freshworks
FRSH
|
$4.48M |
Top Sells
| 1 |
Kinsale Capital Group
KNSL
|
$10.5M |
| 2 |
HealthEquity
HQY
|
$6.56M |
| 3 |
Cytokinetics
CYTK
|
$5.39M |
| 4 |
Hilton Grand Vacations
HGV
|
$5.06M |
| 5 |
Allete
ALE
|
$4.77M |
Sector Composition
| 1 | Financials | 17.18% |
| 2 | Healthcare | 16.22% |
| 3 | Technology | 15.16% |
| 4 | Industrials | 13.74% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.75M | 0.31% |
1,993
-55
| -3% | -$48.3K |
|
102
Arrowhead Research
ARWR
$3.84B
| $1.66M | 0.3% |
54,094
-5,575
| -9% | -$171K |
|
103
Best Buy
BBY
$15.8B
| $1.62M | 0.29% |
20,661
| – | – |
|
104
West Fraser Timber
WFG
$5.63B
| $1.6M | 0.29% |
18,600
| – | – |
|
|
DFS
105
DELISTED
Discover Financial Services
DFS
| $1.56M | 0.28% |
13,923
| – | – |
|
106
AbbVie
ABBV
$374B
| $1.48M | 0.27% |
9,526
-112
| -1% | -$17.4K |
|
107
Extreme Networks
EXTR
$2.87B
| $1.47M | 0.26% |
83,226
-8,875
| -10% | -$157K |
|
108
Alkermes
ALKS
$4.95B
| $1.46M | 0.26% |
52,570
+12,496
| +31% | +$347K |
|
109
Protagonist Therapeutics
PTGX
$3.62B
| $1.43M | 0.26% |
62,327
-6,641
| -10% | -$152K |
|
110
Microsoft
MSFT
$3.76T
| $1.37M | 0.25% |
4,375
+1,226
| +39% | +$385K |
|
111
Owens Corning
OC
$12.4B
| $1.36M | 0.25% |
9,192
| – | – |
|
112
T Rowe Price
TROW
$23.2B
| $1.28M | 0.23% |
11,901
| – | – |
|
113
AllianceBernstein
AB
$4.37B
| $1.2M | 0.22% |
38,559
| – | – |
|
114
Rocket Pharmaceuticals
RCKT
$358M
| $1.09M | 0.2% |
36,311
-21,716
| -37% | -$651K |
|
115
Eli Lilly
LLY
$661B
| $1.03M | 0.18% |
1,763
-122
| -6% | -$71.1K |
|
116
Vertex Pharmaceuticals
VRTX
$102B
| $953K | 0.17% |
2,341
-52
| -2% | -$21.2K |
|
117
Biogen
BIIB
$20.8B
| $934K | 0.17% |
3,610
+1,080
| +43% | +$279K |
|
|
KRTX
118
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $934K | 0.17% |
2,951
+739
| +33% | +$234K |
|
119
Amgen
AMGN
$153B
| $923K | 0.17% |
3,203
+4
| +0.1% | +$1.15K |
|
120
Merck
MRK
$210B
| $838K | 0.15% |
7,689
-495
| -6% | -$54K |
|
121
NVIDIA
NVDA
$4.15T
| $771K | 0.14% |
1,557
| – | – |
|
122
Sarepta Therapeutics
SRPT
$1.98B
| $690K | 0.12% |
7,156
-71
| -1% | -$6.85K |
|
123
BioMarin Pharmaceuticals
BMRN
$11.3B
| $680K | 0.12% |
7,049
+1,392
| +25% | +$134K |
|
124
Amazon
AMZN
$2.41T
| $656K | 0.12% |
4,319
+1,045
| +32% | +$159K |
|
125
Neurocrine Biosciences
NBIX
$13.5B
| $641K | 0.12% |
4,863
| – | – |
|